We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
INPEFA Viatris Pty Ltd
Product name
INPEFA
Sponsor
Accepted date
Oct-2025
Active ingredients
sotagliflozin
Proposed indication
Inpefa (sotagliflozin) is a medicine that is proposed to help lower the chances of dying from heart problems, being hospitalised for heart failure, or needing urgent care for heart failure. It is for adults who either have heart failure, or have type 2 diabetes, long-term kidney disease, and other risks for heart problems.
Application type
A (new medicine)
Publication date
Oct-2025